Literature DB >> 16770261

Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis.

Naomi S Falk1, Paul M Beer, George B Peters.   

Abstract

PURPOSE: To report the use of commercially available triamcinolone acetonide as adjunct treatment for acute-onset endophthalmitis after intraocular procedures.
METHODS: Charts of 14 patients who received intravitreal triamcinolone in combination with intravitreal antibiotics for treatment of acute endophthalmitis were reviewed. Patients were included if they presented with pain, vision loss, and severe anterior chamber reaction or hypopyon. Visual acuities, intraocular pressures, anterior chamber reaction, and view of fundus details were recorded at baseline, 1 day, 1 week, 1 month, and 3 months to 5 months.
RESULTS: Culture-positive results were found for 57% (8/14) of patients. Isolated species included Staphylococcus epidermidis, viridans streptococcus, group D Streptococcus (nonenterococcus), Propionibacterium acnes, and diphtheroid bacilli. Visual acuities improved an average of 7.5 Snellen lines. Preendophthalmitis level visual acuities were recovered in 78.6% patients (11/14), with 64% (9/14) of patients achieving visual acuity of 20/40 or better regardless of presenting vision. Resolution of anterior chamber reaction and view of fundus details were consistent with visual acuities.
CONCLUSIONS: Intravitreal triamcinolone combined with intravitreal antibiotics appears to have a safety profile similar to current modalities with a favorable effect on visual recovery and function in the setting of acute postoperative endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770261     DOI: 10.1097/00006982-200605000-00008

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

Review 1.  A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis.

Authors:  Dawn Ching Wen Ho; Aniruddha Agarwal; Cecilia S Lee; Jay Chhablani; Vishali Gupta; Manoj Khatri; Jayabalan Nirmal; Carlos Pavesio; Rupesh Agrawal
Journal:  Ocul Immunol Inflamm       Date:  2016-11-16       Impact factor: 3.070

2.  Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.

Authors:  Ajay E Kuriyan; Kathleen D Weiss; Harry W Flynn; William E Smiddy; Audina M Berrocal; Thomas A Albini; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2014-01-10       Impact factor: 5.258

Review 3.  Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis.

Authors:  Diem K Bui; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.